thebiostories

Phase 1 Clinical Trials of MK-7602: A Promising New Chapter in the Fight Against Malaria ⏱ In 30 Seconds ✓ MK-7602 is a first-in-class experimental antimalarial drug jointly developed by WEHI and MSD . ✓ It blocks two essential malaria parasite enzymes, plasmepsin IX and plasmepsin X . ✓ Phase 1 studies found that MK-7602 was generally well tolerated in healthy volunteers and reached blood concentrations predicted to have antimalarial activity. ✓ The results mark an important transition from nearly a decade of laboratory research to early clinical development. From Laboratory Discovery to Human Trials For decades, malaria parasites have repeatedly evolved resistance to medicines that once transformed global malaria control, creating an urgent need for drugs that attack the parasite through entirely different biological mechanisms. In March 2026, researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI) reported an important milestone in...

How WEHI Scientists Are Helping Defeat Malaria: From Fundamental Discovery to New Treatments ⏱ In 30 Seconds ✓ Malaria remains a major global health threat because parasites and mosquitoes continue to evolve resistance to existing control measures. ✓ For more than three decades, WEHI scientists have studied how malaria parasites invade, survive and reproduce inside human cells. ✓ These fundamental discoveries have revealed new biological vulnerabilities that can guide the development of medicines and vaccines. ✓ One result of this long research journey is MK-7602 , a first-in-class experimental antimalarial drug that has progressed into human clinical trials. Why Malaria Still Matters Malaria has been one of humanity’s deadliest infectious diseases for thousands of years. Although remarkable progress has been made over the past two decades, the disease still causes hundreds of thousands of deaths each year, with young children in sub-Saharan Africa carrying th...

🌏 Available in: English | 한국어 생명을 구한 발견에서 치료 표적으로 GM-CSF 이야기 ⏱ 30초 요약 ✓ GM-CSF 는 처음에는 백혈구의 생성과 기능을 돕는 성장인자로 발견되었습니다. ✓ 이후 연구를 통해 GM-CSF는 대식세포와 단핵구를 비롯한 다양한 면역세포의 염증 반응을 조절하는 중요한 사이토카인이라는 사실이 밝혀졌습니다. ✓ 이러한 발견은 류마티스관절염과 같은 염증성 질환에서 GM-CSF 또는 그 수용체를 차단하는 치료제 개발로 이어졌습니다. ✓ GM-CSF의 이야기는 하나의 분자가 어떤 상황에서는 생명을 구하는 치료제가 되고, 또 다른 상황에서는 치료 표적이 될 수 있음을 보여주는 대표적인 사례입니다. 호주의 과학자 도널드 메트칼프(Don Metcalf) 와 그의 동료들이 과립구-대식세포 집락자극인자(Granulocyte-Macrophage Colony-Stimulating Factor, GM-CSF) 를 발견했을 때, 그리고 G-CSF와 같은 다른 집락자극인자들을 연구했을 때만 해도, 연구자들은 이것이 백혈구 생성을 조절하는 또 하나의 성장인자라고 생각했습니다. 당시로서는 그 해석이 완전히 맞는 것처럼 보였습니다. GM-CSF는 골수에서 과립구와 대식세포의 생성을 촉진하여 항암화학요법이나 골수이식 후 감소한 면역세포를 회복시키는 분자로 이해되었습니다. 실제로 GM-CSF는 뛰어난 임상적 가능성을 보여주었습니다. 세계적인 테너 호세 카레라스(José Carreras)는 백혈병 치료 과정에서 GM-CSF가 사용된 초기 임상시험에 참여했고, 이는 혈액세포 생물학의 기초 연구가 실제 환자의 생명을 살리는 치료로 이어질 수 있음을 보여주는 대표적인 사례가 되었습니다. GM-CSF에 대한 연구가 계속되면서 백혈구 생성 이외의 역할도 밝혀지기 시작했습니다. 많은 염증성 질환에서는 면역세포의 수뿐 아니라 이들 세포의 행동에도 변화가 나타났습니다. 이들...

🌏 Available in: English | 한국어 From Life-Saving Discovery to Drug Target The Story of GM-CSF ⏱ In 30 Seconds ✓ GM-CSF was first discovered as a growth factor that supports the production and function of white blood cells. ✓ It later became clear that GM-CSF also changes how macrophages, monocytes and other immune cells behave during inflammation. ✓ This led scientists to develop antibodies that block GM-CSF or its receptor in diseases such as rheumatoid arthritis. ✓ The story shows how the same biological pathway can help patients in one setting but become a therapeutic target in another. When Australian scientist Professor Don Metcalf and his colleagues first discovered granulocyte-macrophage colony-stimulating factor (GM-CSF) , together with other colony-stimulating factors such as G-CSF , they believed they had identified another growth factor involved in white blood cell production. For years, that assumption appeared to be correct. GM-CSF was...

🌏 Available in: English | 한국어 Frank Macfarlane Burnet: The Nobel Prize Winner Who Shaped Modern Immunology ⏱ In 30 Seconds ✓ Frank Macfarlane Burnet helped transform modern immunology through the theory of clonal selection . ✓ His ideas helped explain how the immune system distinguishes the body’s own tissues from foreign threats. ✓ Burnet shared the 1960 Nobel Prize in Physiology or Medicine for work on acquired immunological tolerance. ✓ His research helped establish the conceptual foundations of transplantation, autoimmune disease research and modern immune-based medicine. When people think of famous Australian scientists, names such as Howard Florey, Peter Doherty and Elizabeth Blackburn may come to mind first. Frank Macfarlane Burnet is less familiar to the general public, but his influence on modern immunology is difficult to overstate. Burnet did not discover a blockbuster drug. Instead, he helped explain one of the most fundamental pro...